Most importantly, the expression of stem cell markers such as Nanog, Sox2 and Oct4 is closely associated with HNSCC patient’s prognosis, pathological stages, cancer recurrence and therapy resistance [55,56]. The gene discussed is POU5F1; the disease is head and neck squamous cell carcinoma.